Deven Choksey
Tatva Chintan is transitioning into a stronger growth phase primarily driven by SDA recovery, clearer electrolyte-salt commercialization, scalable agro/pharma pipelines, and a structurally high-entry-barrier semiconductor opportunity.
Tatva Chintan Pharma has gained 50.93% in the last 1 Year
More from Tatva Chintan Pharma Chem Ltd.
Recommended